Hearing instruments maker Sonion has entered into a strategic partnership with wearable biometric sensor technology company Valencell to develop biometrics sensors for hearables and hearing health markets.
As part of the alliance, Valencell will supply biometric sensor modules designed for hearables and wearables, which will be optimised by Sonion in terms of size, power consumption and cost to ensure in-ear and on-ear applications.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataIt is expected that Sonion’s expertise in manufacturing miniaturised components for ear-based devices will lead to significant decrease in the required factors for functionalities into ear-level medical devices.
Sonion president and CEO Jesper Ahlmann Funding Andersen said: “Biometric sensing is the next big thing for many of our customers, making the ear-level devices truly multi-functional.
“Joining forces with the global leader in this field – Valencell – brings accuracy and the possibility to add innovative new metrics to the products we develop for our customers, including advanced medical monitoring.”
The companies will primarily work on the design, development and manufacturing of biometric sensing ear modules to cater to the medical, hearing health, professional communications and consumer markets.
Sonion will launch a variety of sensor modules for different applications in the ear and Valencell will further expand its advanced, accurate biometric sensor portfolio.
Valencell CEO Michael Dering said: “This partnership with Sonion brings tremendous value to the hearables and hearing health markets, as well as to our current and future customers and partners.
“Sonion brings world-class expertise and capabilities in hearing health component development, manufacturing, and distribution.”
Under the collaboration, Valencell has also secured an undisclosed strategic investment from Sonion.
